These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2173288)

  • 21. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral activity of Rhus aromatica (fragrant sumac) extract against two types of herpes simplex viruses in cell culture.
    Reichling J; Neuner A; Sharaf M; Harkenthal M; Schnitzler P
    Pharmazie; 2009 Aug; 64(8):538-41. PubMed ID: 19746844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
    Esposito S; Gupta A; Thadepalli H
    Drugs Exp Clin Res; 1987; 13(8):489-92. PubMed ID: 3428131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2.
    Debiaggi M; Pagani L; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):55-61. PubMed ID: 2832710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro effect of combinations of daunorubicin and antibiotics against various bacterial strains].
    Fourche J; Maugein J; Pellegrin JL; Mormede M
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):591-4. PubMed ID: 2677927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
    Kitahara T; Aoyama Y; Hirakata Y; Kamihira S; Kohno S; Ichikawa N; Nakashima M; Sasaki H; Higuchi S
    Int J Antimicrob Agents; 2006 Jan; 27(1):51-7. PubMed ID: 16318911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rapid photometric method for determination of in vitro effectiveness of various antibiotic combinations].
    Bretschneider M; Sandow D; Patsch R; Nguyen TM
    Z Gesamte Hyg; 1991 Feb; 37(2):84-7. PubMed ID: 2031388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "In vivo" and "in vitro" effects of a bacterial extract on Herpes Simplex Virus.
    Bonina L; Focà A; Merendino R; Carbone M
    Boll Soc Ital Biol Sper; 1980 Jun; 56(11):1164-8. PubMed ID: 6255968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins.
    Lampi G; Deidda D; Pinza M; Pompei R
    Antivir Chem Chemother; 2001 Mar; 12(2):125-31. PubMed ID: 11527044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategic design and three-dimensional analysis of antiviral drug combinations.
    Prichard MN; Prichard LE; Shipman C
    Antimicrob Agents Chemother; 1993 Mar; 37(3):540-5. PubMed ID: 8384816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of virus recovery techniques for assessing the virucidal activity of disinfectant spray products.
    Chen JH
    J Assoc Off Anal Chem; 1975 Jan; 58(1):130-2. PubMed ID: 166973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple test for synergy for a small number of combinations.
    Novick SJ
    Stat Med; 2013 Dec; 32(29):5145-55. PubMed ID: 23904140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined antiviral effect of DNA inhibitors on Herpes simplex virus multiplication.
    Wigand R; Hassinger M
    Med Microbiol Immunol; 1980; 168(3):179-90. PubMed ID: 6250018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for testing for synergy with any number of agents.
    Berenbaum MC
    J Infect Dis; 1978 Feb; 137(2):122-30. PubMed ID: 627734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulating the "size of mesh" in drug screening from statistical point of view demonstrated by a 2-step procedure of in vivo testing of antiviral compounds.
    Horn M; Veckenstedt A; Kanka U
    Arzneimittelforschung; 1977; 27(11):2032-5. PubMed ID: 579996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic combinations: should they be tested?
    Eliopoulos GM; Eliopoulos CT
    Clin Microbiol Rev; 1988 Apr; 1(2):139-56. PubMed ID: 3069193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antiviral compounds: acute versus persistent infections in cell cultures.
    Schwöbel W; Streissle G
    Ann N Y Acad Sci; 1977 Mar; 284():599-603. PubMed ID: 212989
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimization of drug combinations using Feedback System Control.
    Nowak-Sliwinska P; Weiss A; Ding X; Dyson PJ; van den Bergh H; Griffioen AW; Ho CM
    Nat Protoc; 2016 Feb; 11(2):302-15. PubMed ID: 26766116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.